NEW YORK, NY / ACCESS Newswire / May 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DMC Global Inc. ("DMC Global" or "the Company") (NASDAQ:BOOM). Investors who purchased DMC Global securities prior to January 29, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/BOOM.

NEW YORK CITY, NY / ACCESS Newswire / May 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Bancorp, Inc. ("Bancorp" or "the Company") (NASDAQ:TBBK). Investors who purchased Bancorp securities prior to January 25, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/TBBK.

NEW YORK CITY, NY / ACCESS Newswire / May 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of EchoStar Corporation ("EchoStar" or "the Company") (NASDAQ:SATS). Investors who purchased EchoStar securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SATS.

NEW YORK CITY, NY / ACCESS Newswire / May 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ichor Holdings, Ltd. ("Ichor" or "the Company") (NASDAQ:ICHR).

ATHENS, Greece and LIVERMORE, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ: ADN) ("Advent "or the "Company"), an innovation-driven leader in the fuel cell and hydrogen technology sector, is pleased to announce that Joseph Hosni has joined the Company as the Director of Commercial Sales. Mr. Hosni will be based at the Company's Athens office.

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, has been selected to provide its RENASYS◊ TOUCH Negative Pressure Wound Therapy (NPWT) Systems under a single award, 10-year* contract for up to $75 million by the U.S. Department of Defense (DoD) through the Defense Logistics Agency (DLA).

Transaction will augment Lilly's efforts to advance non-opioid medicines for pain management INDIANAPOLIS , May 27, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and SiteOne Therapeutics, Inc. ("SiteOne"), a private biotechnology company developing small molecule inhibitors of sodium channels to treat pain and other neuronal hyperexcitability disorders, today announced a definitive agreement for Lilly to acquire SiteOne. The transaction includes STC-004, a Phase 2 ready Nav1.8 inhibitor being studied for the treatment of pain.

Opens Multi-Billion Market Opportunity for the Company First Order for 100 Units Received FORT MILL, S.C., May 27, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced that it has received CE Mark approval for LockeT, the latest advanced vascular closure device.

The U.S. nuclear energy has just reached critical mass. A series of Executive Orders unleashed by the Trump Administration reduced red tape, focusing attention on “advanced nuclear technologies, paving the way for the United States to become a global leader in nuclear technology, fuel, and services.

Media Release COPENHAGEN, Denmark; May 27, 2025 Genmab A/S (Nasdaq: GMAB ) announced today that its C hief F inancial O fficer Anthony Pagano will participate in a fireside chat at the 4 6 th Goldman Sachs Annual Global Health c are Conference in Miami, Florida at 8:00 A M E D T ( 2:00 PM CE S T ) on June 9 , 202 5 . A webcast of the fireside chat will be available on Genmab's website at https://ir.genmab.com/events-presentations.

Bitcoin hovers near $110K as crypto sentiment surges. V, PYPL, and CLSK emerge as top stock picks with rising earnings outlooks.

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, DLH (DLHC) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

Interface (TILE) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

GE Aerospace (NYSE:GE) stock has risen by almost 40% this year, significantly surpassing the S&P 500, which has decreased by 1%. This remarkable surge prompts an important question for investors: Is GE stock now overvalued, and could it face a significant correction, possibly by 25-30% or even 40% to below $150?

Jim Cramer breaks down why he's keeping an eye on shares of CoreWeave.

Quantum computing stocks have become known for their massive volatility, something that rang particularly true on May 22. The most followed pure-play quantum computing stocks skyrocketed that day.

London-listed copper producers are back in the spotlight. UBS has named Antofagasta PLC (LSE:ANTO) and Anglo American PLC (LSE:AAL) among its preferred global picks, highlighting their leverage to constrained supply and long-term demand linked to the energy transition.

DCLI deploys BB's Radar across 100,000 DCL53 domestic 53-foot chassis, driving digital transformation in intermodal logistics.

A MoffettNathanson analyst is cautious on CoreWeave shares but says that “attempting to trade this move appears exceptionally dangerous.”

President Trump has agreed to delay imposing a 50% tariff on EU imports until July 9.